Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05456256 |
| Consolidated Lead Sponsor | Lantern Pharma |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 90 participants (ESTIMATED) |
| Registered Start Date | 2023-03-01 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Fox Chase Cancer Center | Philadelphia, PA | Open Hospital Dossier -> |
| UT Southwestern Simmons Cancer Center | Dallas, TX | Open Hospital Dossier -> |
| Tohoku University Hospital | Sendai, Japan | Open Hospital Dossier -> |
| Okayama University Hospital | Okayama, Japan | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.